Integral Diagnostics Ltd
ASX:IDX

Watchlist Manager
Integral Diagnostics Ltd Logo
Integral Diagnostics Ltd
ASX:IDX
Watchlist
Price: 2.9 AUD Market Closed
Market Cap: 678.4m AUD
Have any thoughts about
Integral Diagnostics Ltd?
Write Note

Intrinsic Value

The intrinsic value of one IDX stock under the Base Case scenario is 6.22 AUD. Compared to the current market price of 2.9 AUD, Integral Diagnostics Ltd is Undervalued by 53%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IDX Intrinsic Value
6.22 AUD
Undervaluation 53%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Integral Diagnostics Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for IDX cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about IDX?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Integral Diagnostics Ltd

Provide an overview of the primary business activities
of Integral Diagnostics Ltd.

What unique competitive advantages
does Integral Diagnostics Ltd hold over its rivals?

What risks and challenges
does Integral Diagnostics Ltd face in the near future?

Has there been any significant insider trading activity
in Integral Diagnostics Ltd recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Integral Diagnostics Ltd.

Provide P/S
for Integral Diagnostics Ltd.

Provide P/E
for Integral Diagnostics Ltd.

Provide P/OCF
for Integral Diagnostics Ltd.

Provide P/FCFE
for Integral Diagnostics Ltd.

Provide P/B
for Integral Diagnostics Ltd.

Provide EV/S
for Integral Diagnostics Ltd.

Provide EV/GP
for Integral Diagnostics Ltd.

Provide EV/EBITDA
for Integral Diagnostics Ltd.

Provide EV/EBIT
for Integral Diagnostics Ltd.

Provide EV/OCF
for Integral Diagnostics Ltd.

Provide EV/FCFF
for Integral Diagnostics Ltd.

Provide EV/IC
for Integral Diagnostics Ltd.

Show me price targets
for Integral Diagnostics Ltd made by professional analysts.

What are the Revenue projections
for Integral Diagnostics Ltd?

How accurate were the past Revenue estimates
for Integral Diagnostics Ltd?

What are the Net Income projections
for Integral Diagnostics Ltd?

How accurate were the past Net Income estimates
for Integral Diagnostics Ltd?

What are the EPS projections
for Integral Diagnostics Ltd?

How accurate were the past EPS estimates
for Integral Diagnostics Ltd?

What are the EBIT projections
for Integral Diagnostics Ltd?

How accurate were the past EBIT estimates
for Integral Diagnostics Ltd?

Compare the revenue forecasts
for Integral Diagnostics Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Integral Diagnostics Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Integral Diagnostics Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Integral Diagnostics Ltd compared to its peers.

Compare the P/E ratios
of Integral Diagnostics Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Integral Diagnostics Ltd with its peers.

Analyze the financial leverage
of Integral Diagnostics Ltd compared to its main competitors.

Show all profitability ratios
for Integral Diagnostics Ltd.

Provide ROE
for Integral Diagnostics Ltd.

Provide ROA
for Integral Diagnostics Ltd.

Provide ROIC
for Integral Diagnostics Ltd.

Provide ROCE
for Integral Diagnostics Ltd.

Provide Gross Margin
for Integral Diagnostics Ltd.

Provide Operating Margin
for Integral Diagnostics Ltd.

Provide Net Margin
for Integral Diagnostics Ltd.

Provide FCF Margin
for Integral Diagnostics Ltd.

Show all solvency ratios
for Integral Diagnostics Ltd.

Provide D/E Ratio
for Integral Diagnostics Ltd.

Provide D/A Ratio
for Integral Diagnostics Ltd.

Provide Interest Coverage Ratio
for Integral Diagnostics Ltd.

Provide Altman Z-Score Ratio
for Integral Diagnostics Ltd.

Provide Quick Ratio
for Integral Diagnostics Ltd.

Provide Current Ratio
for Integral Diagnostics Ltd.

Provide Cash Ratio
for Integral Diagnostics Ltd.

What is the historical Revenue growth
over the last 5 years for Integral Diagnostics Ltd?

What is the historical Net Income growth
over the last 5 years for Integral Diagnostics Ltd?

What is the current Free Cash Flow
of Integral Diagnostics Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Integral Diagnostics Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Integral Diagnostics Ltd

Current Assets 74.8m
Cash & Short-Term Investments 42.4m
Receivables 24.8m
Other Current Assets 7.6m
Non-Current Assets 669.5m
Long-Term Investments 5k
PP&E 270.4m
Intangibles 399.1m
Current Liabilities 85.7m
Accounts Payable 32.8m
Other Current Liabilities 52.9m
Non-Current Liabilities 356.9m
Long-Term Debt 341.6m
Other Non-Current Liabilities 15.3m
Efficiency

Earnings Waterfall
Integral Diagnostics Ltd

Revenue
469.7m AUD
Cost of Revenue
-22.9m AUD
Gross Profit
446.8m AUD
Operating Expenses
-404.6m AUD
Operating Income
42.2m AUD
Other Expenses
-102.9m AUD
Net Income
-60.7m AUD

Free Cash Flow Analysis
Integral Diagnostics Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

IDX Profitability Score
Profitability Due Diligence

Integral Diagnostics Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Positive Free Cash Flow
Positive 3-Years Revenue Growth
48/100
Profitability
Score

Integral Diagnostics Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

IDX Solvency Score
Solvency Due Diligence

Integral Diagnostics Ltd's solvency score is 29/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Average D/E
Short-Term Solvency
Low Altman Z-Score
29/100
Solvency
Score

Integral Diagnostics Ltd's solvency score is 29/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IDX Price Targets Summary
Integral Diagnostics Ltd

Wall Street analysts forecast IDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IDX is 3.21 AUD with a low forecast of 2.53 AUD and a high forecast of 3.9 AUD.

Lowest
Price Target
2.53 AUD
13% Downside
Average
Price Target
3.21 AUD
11% Upside
Highest
Price Target
3.9 AUD
35% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for IDX?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for IDX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

IDX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Integral Diagnostics Ltd Logo
Integral Diagnostics Ltd

Country

Australia

Industry

Health Care

Market Cap

678.4m AUD

Dividend Yield

2%

Description

Integral Diagnostics Ltd. engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied professionals. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-10-21. The firm is principally engaged in providing medical imaging services to patients and their referrers across Australia and New Zealand. The firm offers its services through its three brands in Australian states, which include Lake Imaging in Victoria, South Coast Radiology and Imaging Queensland in Queensland and Apex Radiology in Western Australia. IDX also operates in New Zealand through the Ascot Radiology, SRG Radiology and Trinity MRI brands. The firm has approximately 72 radiology clinics, including 26 comprehensive sites. IDX offers its services through its subsidiaries.

Contact

VICTORIA
Melbourne
Suite 9.02, Level 9, 45 William Street
+61353390704.0
www.integraldiagnostics.com.au

IPO

2015-10-21

Employees

-

Officers

CEO, MD & Director
Dr. Ian Kadish M.B.A., MBBCh
Executive Director
Dr. Jacqueline Milne MBBS
Chief Financial Officer
Mr. Scott Paterson
Chief Information Officer
Mr. Julian Gully
Company Secretary
Mr. John Merity B.A., L.L.B.

See Also

Discover More
What is the Intrinsic Value of one IDX stock?

The intrinsic value of one IDX stock under the Base Case scenario is 6.22 AUD.

Is IDX stock undervalued or overvalued?

Compared to the current market price of 2.9 AUD, Integral Diagnostics Ltd is Undervalued by 53%.

Back to Top